Table 5.
Secondary analysis: subjects surviving >5 days from ICH onset
Variable | All ICH
|
Lobar ICH
|
Deep ICH
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95 % | CI | p value | OR | 95 % | CI | p value | OR | 95 % | CI | p value | |
AED treatment | 1.12 | 0.69 | 1.81 | 0.65 | 1.39 | 0.46 | 4.20 | 0.56 | 1.67 | 0.82 | 3.40 | 0.16 |
Age | 1.03 | 1.01 | 1.05 | 0.005 | 1.03 | 1.00 | 1.07 | 0.08 | 1.04 | 1.01 | 1.07 | 0.01 |
Sex | 1.37 | 0.87 | 2.16 | 0.18 | 0.82 | 0.37 | 1.81 | 0.61 | 1.99 | 0.99 | 4.02 | 0.05 |
Length of hospital stay | 1.01 | 0.99 | 1.02 | 0.44 | 1.02 | 0.98 | 1.07 | 0.26 | 1.00 | 0.98 | 1.02 | 0.89 |
Baseline ICH volume (mL) | 1.03 | 1.02 | 1.04 | <.0001 | 1.04 | 1.02 | 1.05 | <.0001 | 1.04 | 1.03 | 1.06 | <.0001 |
Hypercholesterolemia | 0.85 | 0.53 | 1.36 | 0.49 | 0.67 | 0.28 | 1.59 | 0.36 | 1.06 | 0.53 | 2.13 | 0.87 |
Hypertension | 1.33 | 0.76 | 2.32 | 0.32 | 0.78 | 0.33 | 1.88 | 0.59 | 1.13 | 0.42 | 3.02 | 0.82 |
Atrial fibrillation | 0.74 | 0.37 | 1.49 | 0.40 | 2.65 | 0.93 | 7.59 | 0.07 | 0.36 | 0.11 | 1.17 | 0.09 |
Intraventricular | 1.99 | 1.25 | 3.16 | 0.004 | 0.88 | 0.37 | 2.10 | 0.78 | 1.89 | 0.92 | 3.86 | 0.08 |
Warfarin | 1.56 | 0.78 | 3.12 | 0.21 | 0.47 | 0.13 | 1.73 | 0.25 | 3.42 | 1.21 | 9.70 | 0.02 |